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ARTICLE
TRADD regulates perinatal development and
adulthood survival in mice lacking RIPK1 and RIPK3
John P. Dowling1, Mohamed Alsabbagh1, Christina Del Casale1, Zheng-Gang Liu2 & Jianke Zhang1
TRADD is an adaptor for TNFR1-induced apoptosis and NFκB activation. However, TRADD-
deﬁcient mice undergo normal development and contain normal lymphoid populations, which
contrasts with an embryonic defect in mice lacking FADD, the shared adaptor mediating
apoptosis. Recent studies indicate FADD suppresses embryonic necroptosis mediated by
RIPK1. TRADD was suggested to also mediate necroptosis. Here we report that targeting
TRADD fails to rescue Fadd−/− embryos from necroptosis, and ablation of TRADD rescues
Ripk1−/− mice from perinatal lethality when RIPK3-mediated necroptosis is disabled. The
resulting Ripk1−/−Ripk3−/−Tradd−/− mice survive until early adulthood, but die thereafter. A
single allele of Tradd is optimal for survival of Ripk1−/−Ripk3−/−Tradd+/−mice. We show that
TRADD plays a more dominating role in NFκB-signaling than RIPK1. While RIPK1 protects
thymocytes from TNFα-induced apoptosis, TRADD promotes this process. The data
demonstrate that TRADD is critical in perinatal and adult mice lacking RIPK1 and RIPK3,
which has not been appreciated in prior studies.
https://doi.org/10.1038/s41467-019-08584-5 OPEN
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Programmed cell death (PCD) including apoptosis andnecroptosis plays an important role during development1,2.In the immune system, PCD is required for homeostasis
and suppression of autoimmunity3,4. Signaling through death
receptors (DRs) of the TNFR1/Fas family can lead to PCD5.
Apoptosis is mediated by the Fas associated death domain
(FADD) adaptor protein, which recruits and activates caspase 8
to trigger the apoptotic program6–11. Apoptotic cells are engulfed
by phagocytic cells, preventing spillage of intracellular contents,
and thus limiting tissue damage and inﬂammation12–14. When
apoptosis is blocked, necroptosis (or programmed necrosis) is
initiated by receptor interacting protein kinase (RIPK)1 and
RIPK315–19. These two protein serine/threonine kinases interact
with one another via their RIP homotypic interaction motif
(RHIM). This results in phosphorylation of both RIPK1 and
RIPK3 and recruitment/activation of the mixed lineage kinase
domain like (MLKL) protein. Activated MLKL translocates to and
disrupts the plasma membrane20,21. Loss of membrane integrity
during necroptosis results in the release of cellular contents,
leading to inﬂammatory responses22.
Although FADD and Caspase 8 were initially characterized as
mediators of apoptotic cell death, genetic studies demonstrated
these proteins paradoxically play a major role in preventing
necroptotic cell death. Fadd−/− embryos and Casp8−/− embryos
die in utero and do not survive past embryonic day (E)10.523–25.
Deletion of RIPK1 or RIPK3 corrects the embryonic defect in
Fadd−/− or Casp8−/− mice26–28. Furthermore, deletion of RIPK3
completely restores normal development of Fadd−/− or Casp8−/−
mice27–29. The resulting Casp8−/−Ripk3−/− or Fadd−/−Ripk3−/−
double knockout (DKO) mice develop progressive lymphadeno-
pathy and splenomegaly, a hallmark of lymphoproliferative (lpr)
diseases.
Although RIPK1 (RIP or RIP1) was originally cloned as a
Fas-interacting protein, deletion of RIPK1 results in perinatal
lethality30, while Fas is dispensable in mouse development.
Moreover, conditional deletion of RIPK1 speciﬁcally in T cells
does not affect Fas-induced apoptosis31. Ripk1−/− mice sur-
vive into late adulthood only when apoptosis is blocked by
ablation of FADD or Caspase 8 and necroptosis is blocked by
ablation of RIPK329,32–34. When only necroptosis is blocked,
Ripk1−/−Ripk3−/− mice die within several days after birth.
TRADD is the primary adaptor for TNFR1 and can induce
both apoptosis and NFκB activation35,36. However, Tradd−/−
mice are viable and show no apparent developmental
abnormality, despite defective TNFR1-mediated apoptosis and
NFκB and MAPK signaling in Tradd−/− cells37–39. TRADD
also mediates apoptosis and activation of NFκB and MAPK
signaling through toll-like receptor (TLR)3 and TLR4 as well
as other DRs38,40. It has been suggested that TRADD, like
RIPK1, can mediate necroptosis38. A better understanding of
how TRADD ﬁts into current models of cell death induction
and regulation is essential to uncover a more complete picture
of apoptotic and necroptotic signaling.
Here, we report an approach to investigate the physiological
function of TRADD by employing unique animal models. The
data indicates that TRADD plays no role in embryonic
necroptosis in Fadd−/− mice. However, the study uncovers a
critical function for TRADD in mouse perinatal development as
well as in adult mouse survival in the absence of RIPK1 and
RIPK3. Moreover, TRADD is essential for lymphocyte survival
in adult mice. The data show that TRADD mediates both
apoptosis and NFκB activation. A single allele of TRADD is
optimal for survival of of Ripk1−/−Ripk3−/− mice, indicating a
Goldilocks principle.
Results
TRADD is dispensable for necroptosis in mouse embryos. In
agreement with previous analysis of Casp8−/− mice33, we found
that lack of TNFα improves the survival of Fadd−/− embryos
(Supplementary Fig. 1), indicating that TNFR1-mediated
necroptosis is partially responsible for embryonic death.
TRADD is suggested to be the primary adaptor for TNFR1 and
likely mediates both apoptosis and NFκB activation35,36. How-
ever, Tradd−/− mice exhibit no apparent defect in development
and contain a normal hematopoietic compartment37–39. TRADD
was also suggested to mediate TNFα-induced necroptosis38.
However, we found that absence of TRADD failed to rescue
Fadd−/− embryos from death (Supplementary Fig. 2).
Ripk1−/− or Ripk1−/−Fadd−/− mice undergo normal embry-
ogenesis but die within one day of birth due to RIPK3-mediated
necroptosis26,30. In contrast, Ripk1−/−Fadd−/−Ripk3−/− mice are
viable, indicating that RIPK3-mediated necroptosis is the leading
cause of perinatal lethality in Ripk1−/−Fadd−/− mice29,32–34.
Given possible functional redundancy between TRADD and
FADD for apoptotic signaling and potential functional redun-
dancy between TRADD and RIPK1 for NFκB signaling, we
analyzed the impact of TRADD inactivation on the survival of
Ripk1−/− or Ripk1−/−Fadd−/− mice. As shown in Supplementary
Fig. 3, all Ripk1−/−Tradd−/− mice died within one day of birth
and were indistinguishable from Ripk1−/− mice, indicating that
deletion of TRADD has no survival beneﬁt in Ripk1−/− mice. In
addition, intercross of Ripk1+/−Fadd+/−Tradd−/− mice yielded
no viable Ripk1−/−Fadd−/−Tradd−/− mice at weaning age
(Supplementary Fig. 3a, c), unlike the normal postnatal develop-
ment seen in Ripk1−/−Ripk3−/−Fadd−/− mice described in prior
studies29,32–34. In total, the data indicate that TRADD does not
mediate lethal necroptosis in Fadd−/− embryos or in Ripk1−/−
and Ripk1−/−Fadd−/− neonates.
TRADD deletion in Ripk1−/−Ripk3−/− mice. We performed
further analysis to evaluate the in vivo function of TRADD in
apoptosis using Ripk1−/−Ripk3−/− mice, in which necroptosis is
blocked. To this end, viable Ripk1+/−Ripk3−/−Tradd−/− mice
were generated and intercrossed. Weaning age
Ripk1−/−Ripk3−/−Tradd−/− triple knockout (TKO) mice were
detected at expected Mendelian frequencies (Fig. 1a), which is in
sharp contrast to the perinatal lethality exhibited by
Ripk1−/−Ripk3−/− neonates (Fig. 1b). This data provides in vivo
evidence that a TRADD-mediated signaling pathway blocks
perinatal mouse development in the absence of RIPK1 and
RIPK3. However, Ripk1−/−Ripk3−/−Tradd−/− mice fail to thrive
in adulthood and progressively lose weight over a period of
several weeks (Fig. 1b–d). Histological analysis of the
Ripk1−/−Ripk3−/−Tradd−/− large intestine showed an obvious
loss of goblet cells and massive immune cell inﬁltration in the
TKO intestine (Fig. 1e). In addition, elevated levels of activated
caspase 3 (CC3) were evident in the large intestine of the
Ripk1−/−Ripk3−/−Tradd−/− TKO mice, when compared to wild-
type control mice (Fig. 1e). Among the mice analyzed, the longest
survival is postnatal day (P)78, when the moribund animal was
euthanized (Fig. 1b).
To understand the role of TRADD in adult mice further,
analysis was performed with intercross of triple heterozygous
(THZ) Ripk1+/−Ripk3+/−Tradd+/− mutant mice. Interestingly,
heterozygosity of both RIPK3 and TRADD was sufﬁcient for
Ripk1−/− mice to survive from birth to weaning age (Fig. 2a).
Among the resulting Ripk1−/−Ripk3+/−Tradd+/− mutant mice
analyzed, survival up to P85 was observed, when the moribund
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animal was euthanized (Fig. 2b). Remarkably, retaining just one
wild-type allele of the Tradd gene provides better survival than
two wild-type alleles (Tradd+/+) or two KO alleles (Tradd−/−)
for adult Ripk1−/−Ripk3−/− mice (Fig. 2a–c). Weaning age
Ripk1−/−Ripk3−/−Tradd+/− mice are found at expected
Mendelian frequencies (Fig. 2a) and survived normally through-
out adulthood (Fig. 2b), in contrast to Ripk1−/−Ripk3−/−
Tradd−/− mice, which die in early adulthood (Fig. 1b). Ripk1−/−
Ripk3−/−Tradd+/− mice are indistinguishable in appearance and
weight from wild-type controls (Fig. 2c, d), and are fertile. In
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Fig. 1 Deletion of TRADD improves the survival of Ripk1−/−Ripk3−/− into young adulthood. a Actual and expected frequencies of pups at weaning age from
intercrosses of Ripk1+/−Ripk3−/− Tradd−/− mice. Chi square analysis shows no signiﬁcant difference between actual and expected (p= 0.472).
b Kaplan–Meier plot showing survival of mice of indicated genotypes. Logrank tests shows a signiﬁcant increase in survival of Ripk1−/− Ripk3−/− Tradd−/−
mice, compared to Ripk1−/− Ripk3−/− mice (p < 0.0001) but signiﬁcantly less than WT mice (p < 0.0001). cWeights of Ripk1−/− Ripk3−/− Tradd−/− mice
and littermate controls over time presented as mean ± SEM, *p < 0.05 as determined by Student’s t test. d Three week old and two month old Ripk1−/−
Ripk3−/− Tradd−/− mice (*) with littermate controls (n= 5 independent experiments). e Hematoxylin and eosin (H&E) and cleaved caspase 3 (CC3)
staining of the large intestine of indicated genotypes (n= 3 independent experiments). Scale bars are 50 μm
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addition, Ripk1−/−Ripk3−/−Tradd+/− mice were similar to wild-
type mice with minimal levels of activated caspase 3 in the large
intestine (Fig. 2e), unlike Ripk1−/−Ripk3−/−
Tradd−/− mice, which show greatly elevated active caspase 3
levels in the large intestine (Fig. 1e). Ripk1−/−Ripk3−/−Tradd+/−
mice older than 6 months display no enlargement of the
lymphoid organs (Supplementary Fig. 4a) nor presence of the
abnormal CD3+B220+ population (Supplementary Fig. 4b), the
typical symptoms of lymphoproliferative (lpr) disease present in
Fas−/− mice. This contrasts the severe lpr phenotype in
Fadd−/−Ripk3−/− or Fadd−/−Ripk3−/−Ripk1−/− mice shown
previously by others and us (Supplementary Fig. 4)29,32–34.
A T cell defect in adult Ripk1−/−Ripk3−/−Tradd−/− mice.
Tradd−/− mice contain normal lymphocyte populations, indi-
cating a dispensable role for TRADD in lymphopoiesis38. Here,
we show that in young adult mice (7–8 week old), the lymphoid
organs of Ripk1−/−Ripk3−/−Tradd+/− mice are indistinguishable
from wild-type controls despite a reduction of TRADD protein
levels and the absence of RIPK1 and RIPK3 (Supplementary
Fig. 5). However, deletion of both TRADD alleles results in an
enlarged spleen in Ripk1−/−Ripk3−/−Tradd−/− mice
(Supplementary Fig. 5b, c). Flow cytometric analysis indicates
that the spleen of Ripk1−/−Ripk3−/−Tradd−/− mice contain an
increased Mac+Gr1+ myeloid cell population (Supplementary
Fig. 6,a). The thymus is signiﬁcantly reduced by size and weight
(Supplementary Fig. 5b, c) and thymic cellularity was also greatly
decreased compared with WT controls (Supplementary Fig. 5d).
Flow cytometric analysis showed a major reduction of the
immature CD4+CD8+ double positive population in the thymus
of Ripk1−/−Ripk3−/−Tradd−/− mice (Fig. 3a), indicating
impaired T cell development. Further analysis of the peripheral
lymphoid organs showed that the spleen and lymph nodes
exhibited a marked reduction of CD3+ T cell numbers of both
CD4+ and CD8+ lineages (Fig. 3a–c), resulting in a dramatic T
lymphopenia. In addition, Ripk1−/−Ripk3−/−Tradd−/− mice
have signiﬁcantly reduced bone marrow cell numbers (Supple-
mentary Fig. 5d). Flow cytometric analysis of the B line-
age showed a decrease in B220loIgM− pro/pre B cells in
the bone marrow and no apparent defect in the periphery in
Ripk1−/−Ripk3−/−Tradd−/− mice (Supplementary Fig. 6b, c).
TRADD mediates apoptosis in T cells. Given the pronounced
defect in T cell development in the thymus and T-lymphopenia in
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Fig. 2 Haplosufﬁciency of TRADD rescues the lethality of Ripk1−/−Ripk3−/− mice. a Expected and actual frequencies of pups at weaning age from a triple
heterozygous cross of Ripk1+/−Ripk3+/−Tradd+/− mice. b Kaplan-Meier plot showing survival of mice of indicated genotypes. Logrank tests showed
Ripk1−/−Ripk3−/−Tradd+/− mice exhibited improved survival over Ripk1+/−Ripk3−/−Tradd+/− and Ripk1−/−Ripk3+/−Tradd−/− mice (p < 0.0001). c One
month old mice of indicated genotypes (n= 5 independent experiments). d Weights of Ripk1−/−Ripk3−/−Tradd+/− mice and littermate controls over time
presented as mean ± SEM. t test shows no signiﬁcant difference between groups. e H&E and cleaved caspase 3 (CC3) staining of the large intestine of
indicated genotypes (n= 3 independent experiments). Scale bars are 50 μm
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the periphery in Ripk1−/−Ripk3−/−Tradd−/−mice, we performed
analysis of thymocytes for their ability to respond to stimuli
through the DRs. WT, Ripk1−/−Ripk3−/−Tradd+/−, and
Ripk1−/−Ripk3−/−Tradd−/− thymocytes were similarly sensitive
to Fas-induced cell death (Supplementary Fig. 7a). By contrast,
Ripk1−/−Ripk3−/−Tradd+/− thymocytes readily undergo TNFα-
induced cell death (Fig. 4a). However, wild-type and
Ripk1−/−Ripk3−/−Tradd−/− thymocytes were equally resistant to
TNFα. This is also true of mature peripheral T cells from the
genotypes tested, which all undergo Fas-mediated apoptosis but
only Ripk1−/−Ripk3−/−Tradd+/− cells are sensitive to TNFα-
induced cell death (Supplementary Fig. 7b, c). Ripk1−/−
Ripk3−/−Tradd+/− thymocytes are also sensitive to cell death
induced by human TNFα, which binds to TNFR1 and not
TNFR241 (Supplementary Fig. 7d). In addition, blocking of
TNFR1, but not TNFR2, largely prevents this cell death (Sup-
plementary Fig. 7e). These data indicate that lack of RIPK1 sen-
sitizes thymocytes to TRADD-mediated apoptosis induced by
TNFα through TNFR1.
We also performed analysis of TCR-induced responses. The
data show an increased PI+ population in Ripk1−/−
Ripk3−/−Tradd−/− TKO T cells after 48 h TCR stimulation,
than wild type control T cells (Fig. 4b). Cell division barely
occurred in Ripk1−/−Ripk3−/−Tradd−/− TKO T cells stimulated
through the TCR for 48 h, as compared to wild-type control
T cells. A single wild-type allele of TRADD provided improve-
ment, as indicated by an intermediate phenotype in
Ripk1−/−Ripk3−/−Tradd+/− T cells, which displayed moderately
decreased cell death and moderately increased proliferation, when
compared to Ripk1−/−Ripk3−/−Tradd−/− TKO T cells (Fig. 4b).
The defect in Ripk1−/−Ripk3−/−Tradd+/− T cells remains
signiﬁcant when compared with wild-type T cells.
To determine the nature of the TCR-induced cell death, T cells
were treated with the wide-spectrum caspase inhibitor zVAD-
fmk. This treatment rescued Ripk1−/−Ripk3−/−Tradd−/− T cells
from death during TCR stimulation (Fig. 4b). Moreover, zVAD
treatments greatly improved TCR-induced cell division/prolifera-
tion in Ripk1−/−Ripk3−/−Tradd−/− T cells as well as in
Ripk1−/−Ripk3−/−Tradd+/− T cells (Fig. 4b). Therefore, these
mutant TKO T cells undergo enhanced apoptosis in response to
TCR stimulation, despite a resistance to TNFα-induced apoptosis
(Fig. 4a). To understand further the enhanced apoptosis
phenotype, western blotting analysis was performed to examine
anti-apoptotic proteins. Freshly isolated resting Ripk1−/−
Ripk3−/−Tradd−/− T cells have lower expression of cFLIP than
in Ripk1−/−Ripk3−/−Tradd+/− and WT T cells (Fig. 4c). In
contrast, Bcl-XL is barely detectable in freshly isolated resting
T cells, and is highly induced at 16 h post stimulation with anti-
CD3/CD28 antibodies (Fig. 4c). This TCR-induced Bcl-XL
expression is severely impaired in Ripk1−/−Ripk3−/−Tradd−/−
T cells, as compared to Ripk1−/−Ripk3−/−Tradd+/− and WT
T cells (Fig. 4c). These two proteins are critical for T cell survival
by inhibiting apoptosis and are target genes of the pro-survival
NFκB pathway. Ripk1−/−Ripk3−/−Tradd−/− T cells do appear to
have reduced NFκB signaling, as indicated by reduced phosphor-
ylation of NFκB p65 (Supplementary Fig. 8a). Ripk1−/−
Ripk3−/−Tradd−/− T cells also display elevated caspase activation
upon stimulation (Supplementary Fig. 8b). Similarly, signiﬁcantly
elevated active caspase 3 levels were present in Ripk1−/−
Ripk3−/−Tradd−/− large intestine (Supplementary Fig. 8c). In
total, a single wild-type Tradd allele is advantageous for
Ripk1−/−Ripk3−/− T cell survival after stimulation through the
TCR. Moreover, the data clearly indicate that TRADD has a dual
function in T cells.
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Fig. 3 Ripk1−/−Ripk3−/−Tradd−/− mice display impaired T cell development and T lymphopenia in young adulthood. a, b Representative two-color ﬂow
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A critical role for TRADD in TNFα-mediated NFκB signaling.
The ability to activate this pathway by TNFα was analyzed by
examining induction of phosphorylation of NFκB p65 (p-p65) in
mouse ﬁbroblasts. In WT ﬁbroblasts rapid phosphorylation of
p65 was induced within 5 min of TNFα treatment, but NFκB
activation is completely blocked in Ripk1−/−Ripk3−/−Tradd−/−
ﬁbroblasts (Fig. 4d). A single allele of TRADD in Ripk1−/−
Ripk3−/−Tradd+/− ﬁbroblasts results in an intermediate pheno-
type, that is a delayed activation of the NFκB pathway (Fig. 4d).
We treated wild-type and mutant ﬁbroblasts with LPS and ana-
lyzed NFκB induction. Ripk1−/−Ripk3−/−Tradd−/− ﬁbroblasts
were capable of phosphorylating NFκB, albeit at slightly lower
levels than WT ﬁbroblasts (Fig. 4e). In total, TRADD is essential
for TNFα-induced NFκB activation in Ripk1−/−Ripk3−/− ﬁbro-
blasts, but is dispensable for LPS-induced NFκB activation.
It is possible that the loss of DP thymocytes in Ripk1−/−
Ripk3−/−Tradd−/− (Fig. 3a) is secondary to the wasting disease
(Fig. 1c). To this end, we analyzed younger mice (3 week old)
which have no apparent wasting disease. The lymphoid organs of
young Ripk1−/−Ripk3−/−Tradd−/− mice are normal, as com-
pared to WT controls (Supplementary Fig. 9a). There was no
obvious defect in the thymus, and mature T cell numbers in
lymph nodes was reduced in Ripk1−/−Ripk3−/−Tradd−/− mice
(Supplementary Fig. 9b, c). Thymocytes isolated from 3 week old
Ripk1−/−Ripk3−/−Tradd−/− mice are also resistant to TNFα-
induced cell death unlike Ripk1−/−Ripk3−/−Tradd+/− thymo-
cytes (Supplementary Fig. 10), similar to the result in Fig. 4a. We
performed analysis of NFκB target genes in TNFα-treated
ﬁbroblasts, and the data indicates impaired NFκB signaling in
TKO cells. TNFAIP3 (or A20), an NFκB target gene, is
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downregulated in Ripk1−/−Ripk3−/−Tradd−/− (TKO), compared
to WT ear ﬁbroblasts and is downregulated to a lesser degree
in Ripk1−/−Ripk3−/−Tradd+/− cells (Supplementary Fig. 11).
We further analyzed in vivo response to TNFα treatment, by
intravenous administration in mice. Ripk1−/−Ripk3−/−Tradd+/−
mice displayed a rapid drop in body temperature and succumbed
to TNFα-induced shock, similar to WT mice (Fig. 5a, b).
However, Ripk1−/−Ripk3−/−Tradd−/− mice and Ripk3−/− mice
did not display a signiﬁcant drop in body temperature and did
not succumb to TNFα-induced shock (Fig. 5a, b).
Discussion
The TRADD protein was identiﬁed almost a quarter century ago,
as a potential adaptor molecule for TNFR1 signaling35. It was not
until the ﬁrst TRADD KO mice were generated in the year 2008
that the interrogation of the physiological function of TRADD
became possible37–39. However, Tradd−/− mice show no appar-
ent developmental defect, which is in sharp contrast to the
perinatal lethality in Ripk1−/− mice30, and to the mid-gestation
lethality in Fadd−/− mice23,24,26. Furthermore, Tradd−/− mice
contain a normal lymphoid compartment, while conditional
deletion of RIPK1 or FADD results in T lymphopenia in the
periphery31,42. These observations appear to indicate TRADD
being dispensable during mouse development and lymphocyte
development.
Despite having no impact on mouse development, deletion of
the necroptosis effector protein kinase RIPK3 completely rescues
Fadd−/− mice from embryonic lethality, and the resulting
Fadd−/−Ripk3−/− DKO mice show progressive lymphoproli-
ferative disease after reaching adulthood29. The fact that absence
of TRADD is unable to rescue the embryonic defect in Fadd−/−
mice (Supplementary Fig. 2) indicates that TRADD is dispensable
for necroptotic signaling in vivo. Previous studies have indicated
a potential role for TRADD in necroptosis, as indicated by
Tradd−/− MEFs being resistant to treatment with TNFα, cyclo-
heximide and zVAD (TCZ)38. This observation also contrasts the
normal embryogenesis in Fadd−/−Ripk1−/− mice26. Therefore,
necroptosis in embryonic cells is TRADD-independent and
occurs directly via RIPK1 in vivo when FADD-mediated apop-
tosis is inactivated.
Mice lacking the adaptor kinase RIPK1 die shortly after birth,
and blocking necroptosis through deletion of the downstream
RIPK3, or blocking apoptosis via deletion of FADD provides little
survival advantage, because the resulting Fadd−/−Ripk1−/− or
Ripk1−/−Ripk3−/− DKO mice die within several days after
birth26,29,32,33. Only when both RIPK3 and FADD are deleted do
Ripk1−/− mice survive to adulthood29,32,33. The striking obser-
vation in the current study that deletion of TRADD rescues
Ripk1−/−Ripk3−/− mice from perinatal lethality (Fig. 1) indicates
that TRADD, similar to FADD, may mediate apoptosis in neo-
natal Ripk1−/−Ripk3−/− mice and cause perinatal death. There-
fore, a lack of phenotype in Tradd−/− mice is due in part to the
presence of RIPK1.
Although both FADD and TRADD mediate apoptosis, func-
tional distinction between these two adaptors is evident. Unlike
Ripk1−/−Ripk3−/−Fadd−/− mice, which have normal postnatal
development, Ripk1−/−Ripk3−/−Tradd−/− mice show greatly
diminished post-weaning survival (Fig. 1b). The lethality in
young adulthood may be explained in part by the severe defect in
the intestine in Ripk1−/−Ripk3−/−Tradd−/− mice (Fig. 1e). The
elevated Caspase 3 activation is indicative of enhanced apoptosis
in the intestine when both alleles of Tradd are inactivated in
Ripk1−/−Ripk3−/− mice (Fig. 1e). Interestingly, these symptoms
are reversed by retaining a single wild-type allele of Tradd in
Ripk1−/−Ripk3−/− mice (Fig. 2), contrasting heterozygosity of
FADD which is not sufﬁcient to prevent lethality in
Ripk1−/−Ripk3−/− mice during perinatal development29. While
reducing apoptosis in the intestine, the rescue through haplo-
sufﬁciency of TRADD did not lead to lymphadenopathy and
splenomegaly in the resulting Ripk1−/−Ripk3−/−Tradd+/− mice
(Supplementary Fig. 4), unlike the severe lpr-like symptom in
Ripk3−/−Fadd−/− or Ripk1−/−Ripk3−/−Fadd−/− mice (Supple-
mentary Fig. 4)29,33.
In addition to the intestinal defect, Ripk1−/−Ripk3−/−
Tradd−/− TKO mice display severe T lymphopenia (Fig. 3).
Interestingly, like in wild-type mice, TKO thymocytes and per-
ipheral mature T cells are resistant to cell death triggered by
TNFα (Fig. 4a and Supplementary Fig. 7,b). However, presence of
one allele of wild-type TRADD rendered Ripk1−/−Ripk3−/−
thymocytes and mature T cells hypersensitive to TNFα-induced
death (Fig. 4a and Supplementary Fig. 7b, d). In total, the data
argue that TRADD indeed mediates TNFα-induced apoptosis in
T cells, when RIPK1 is absent. Therefore, T lymphopenia in the
Ripk1−/−Ripk3−/−Tradd−/− mice is counterintuitive, given that
thymocytes from these TKO mice are completely resistant to
TNFα-induced apoptosis. This paradox can be explained in part
by the defect in TCR-induced survival and proliferative responses
in peripheral mature Ripk1−/−Ripk3−/−Tradd−/− TKO T cells
(Fig. 4b). More importantly, TRADD haplosufﬁciency, as
observed in Ripk1−/−Ripk3−/−Tradd+/− mice, indicates a dual
role for TRADD in signaling TCR-induced survival and pro-
liferative responses (Fig. 4b).
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The severely impaired proliferative responses to TCR stimu-
lation in Ripk1−/−Ripk3−/−Tradd−/− TKO mice appear to be
due largely to caspase-dependent apoptosis, because the wide-
spectrum caspase inhibitor zVAD suppressed TCR-induced death
in Ripk1−/−Ripk3−/−Tradd−/− TKO T cells and improved cell
division/proliferation (Fig. 4b and Supplementary Fig. 8,b). It is
important to iterate that death receptor-induced apoptosis is not
affected by deletion of TRADD, as the TKO T cells behave
similarly to wild-type T cells in response to stimulation of Fas and
TNFR1 (Fig. 4a and Supplementary Fig. 7a–c). Therefore, the
result in Fig. 4b implies a role for TRADD in TCR-induced
survival signaling, beyond its role in promoting TNFR1-induced
apoptosis as it does in perinatal cells.
One possible explanation for the improved survival of
Ripk1−/−Ripk3−/−Tradd+/− cells and mice is the requirement for
TRADD in NFκB signaling. Indeed, we found that dermal
ﬁbroblasts of adult TKO mice show a complete blockage of
TNFα-mediated NFκB signaling as shown by lack of phosphor-
ylation of p65 (Fig. 4d). This indicates that TRADD is essential
for NFκB signaling in the absence of RIPK1. Due to the severe
defects in the intestines and T cells of TKO mice, there may be a
cell type-speciﬁc requirement for TRADD-mediated NFκB sig-
naling to prevent apoptosis. Further supporting this notion is the
observation that TKO T cells have lower expression of the NFκB
targets, cFLIP and Bcl-XL, as compared with Ripk1−/−
Ripk3−/−Tradd+/− or wild-type cells (Fig. 4c). In total, similar to
RIPK1 and FADD, TRADD can also initiate or protect against
cell death depending on the conditions and cell type.
In summary, the ﬁndings in the current study identify a pre-
viously unappreciated role for TRADD during perinatal devel-
opment and in adult mice lacking RIPK1 and RIPK3. Gene
dosage of TRADD elicits a Goldilocks effect on the survival of
Ripk1−/−Ripk3−/− mice, whereby Tradd+/+ and Tradd−/−
results in death by apoptosis while haplosufﬁciency of TRADD
proves to be optimal for survival. These ﬁndings demonstrate the
interplay between cell death and NFκB signaling, identify
TRADD as a key component in cell death regulation, and provide
insight into the workings of the apoptotic pathway in the pre-
sence and absence of RIPK1.
Methods
Mice. Both males and females of mus musculus in a C57BL/6 background were
used. Tradd−/− mice were provided by Liu38. Ripk1+/− mice were provided by
Kelliher30. Ripk3−/− mice were provided by Newton and Dixit43. All mice were
bred and housed in a speciﬁc pathogen free environment at Thomas Jefferson
University. After intercrosses of indicated mice, neonates were monitored daily for
survival from birth to weaning age and deceased pups were immediately collected
and genotyped. Viable pups were genotyped at weaning age and monitored for
survival. Kaplan–Meier survival curves were generated using Prism software
(Graphpad Software, Inc.). All animal studies are approved by the Institutional
Animal Care and Use Committee (IACUC) at Thomas Jefferson University. For
genotyping, DNA was isolated from the ear of mice with an alkaline lysis solution
containing 25 mM NaOH and 0.2 mM EDTA followed by neutralization with 40
mM Tris-HCl pH 5.0. Allele speciﬁc primers were used to amplify wild type and
knockout alleles as previously described for Fadd23 (WT primers: 5′- ATG GAC
CCA TTC CTG GTG CTG CTG-3′; 5′-CAG TAG ATC GTG TCG GCG CAG
CG-3′ and KO primers: 5′-ACTGTAGTGCCCAGCAGAGACCAGC -3′; 5′-
CGCTCGGTGTTC
GAGGCCACACGC-3′); Ripk130 (WT&KO primers: 5′-CTGCTAAAGCGCAT
GCTC-3′; 5′-TGTGTCAAGTCTCCCTGCAG-3′; 5′-CACGGTCCTTTTGC
CCTG-3′); Tradd38 (WT primers: 5′-CACTGACTCTTCAAGACCAGCAGAC-3′;
5′-CAACAGATCCTCTGCTAGACTAGTG-3′ and KO primers: 5′-TGCA
CATGTGTCCTCGAGTG-3′; 5′-GGAGAGCTTGGCTGTCTTGG-3′); Ripk343
(WT&KO primers: 5′-CGCTTTAGAAGCCTTCAGGTTGAC-3′; 5′-
GCCTGCCCATCAGCAACTC-3′; 5′-CCAGAGGCCACTTGTGTAGCG-3′).
Embryo analysis. Mating of Fadd+/−Tradd−/− mice was setup in the evening and
females were checked in the morning. When vaginal plug was detected, embryos
were designated E0.5. Embryos were isolated from pregnant mice at E12.5-E18.5
and genotyped as described above.
Cell culture including ﬁbroblast and T cell preparation. Thymocytes and per-
ipheral T cells puriﬁed from spleen and lymph nodes were cultured in complete
RPMI media (cRPMI) containing 10% FBS, 2 mM L-Glutamine, penicillin
(100 U/mL), streptomycin (100 μg/mL), and β-mercaptoethanol (50 μM). Fibro-
blasts were isolated from the ears of euthanized adult mice was adapted from
previously established protocol44. In summary, ears were sterilized with 70%
ethanol and cut into small pieces. Ear pieces were incubated with warm 0.25%
trypsin at 37 °C, 5% CO2 for 90 min, then broken up and passed through a cell
strainer with complete DMEM (cDMEM) containing 10% FBS, 1mM L-Glutamine,
penicillin (100 U/mL), streptomycin (100 μg/mL), and β-mercaptoethanol (50 μM).
Isolated cells were washed once in cDMEM and cultured on tissue culture-treated
plates at 37 °C, 5% CO2.
Histology. Intestines were prepared for histology using the swiss roll technique
followed by ﬁxation in 10% formalin for 24 h. Samples were washed in PBS, placed
in 70% ethanol, and then embedded in formalin. Sections were stained with
hematoxylin and eosin or with anti-cleaved caspase 3 antibody (Cell Signaling
Technology #9661).
Flow cytometry. Spleen, lymph nodes, and thymus were isolated during mouse
dissection. Bone marrow was isolated from tibias and femurs of mice. Single cell
suspension was prepared and red blood cells were depleted by hypotonic lysis. Cells
were stained on ice for 30 minutes in PBS containing 3% BSA, 1 mM EDTA, and
0.05% sodium azide with ﬂuorochrome-conjugated antibodies anti-CD3 (BD
Biosciences, clone 17A2), anti-CD4 (BD Biosciences, clone GK1.5), anti-CD8
(Caltag, clone CT-CD8a), anti-B220 (Caltag, clone RA3-6B2), anti-IgM (Jackson
ImmunoResearch, 115-116-075), anti-Mac1 (BD Biosciences, clone M1/70), anti-
Gr1 (eBioscience, clone RB6-8C5). Samples were washed twice with PBS. Data was
acquired on LSR II ﬂow cytometric analyzer (BD Biosciences) and analyzed using
FlowJo software (Treestar). Total cell numbers were counted on Countess Auto-
mated Cell Counter (Invitrogen) and lymphocyte cellularity was determined by
multiplying the total cell number of indicated organ by percentage of CD3+ or
B220+ cells within the organ obtained by ﬂow cytometry.
Cell death assays. Thymocytes (105) or puriﬁed mature peripheral T cells were
seeded in triplicate in 96 well ﬂat-bottom plates in cRPMI with various con-
centrations of anti-Fas antibody (BD Biosciences, clone Jo2), mouse TNFα (Alexis
Pharmaceuticals), or human TNFα (Life Technologies) for 16 h with cyclohex-
imide. In indicated experiments, thymocytes were pre-treated with TNFR1 or
TNFR2 blocking antibodies (Life Technologies) in complete RPMI on ice for 4 h
before TNFα treatment. Mature peripheral T cells were treated with FLAG-tagged
sFasL (Alexis Pharmaceuticals) and anti-FLAG M2 antibody (1 μg/mL, Sigma).
After incubation, 1 μg/mL propidium iodide (PI) and the percentage of cell death
was analyzed by ﬂow cytometry as determined by PI+ cells.
T cell proliferation assays. Mature T cells were puriﬁed of the spleen and lymph
nodes by staining with anti-Thy1.2 antibody (BD Biosciences, clone 53–2.1) and
sorting Thy1.2+ cells using a FACS Aria (BD Biosciences). For ﬂuorescent labeling,
puriﬁed T cells (106/mL) were labeled with 1 μM CellTraceTM Violet in PBS for 20
min at 37 °C, 5% CO2. cRPMI (5 mL) was added to each tube and incubated for an
additional 5 min at 37 °C 5% CO2. Labeled cells were then centrifuged for 5
minutes, supernatant was removed, and cells were resuspended in cRPMI. Labeled
T cells (2 × 105) were seeded in 96 well round bottom plates pre-coated with 5 μg/
mL anti-CD3 (BD Biosciences, clone 145-2C11) in cRPMI with 1 μg/mL anti-CD28
antibodies (BD Biosciences, clone 37.51). At indicated time points, T cells were
collected, 1 μg/mL PI was added, and cells were analyzed by two-color ﬂow cyto-
metry on the LSR II (BD Biosciences) for cell death and division kinetics. Data was
analyzed using FlowJo software (Treestar). Caspase activities in puriﬁed mature
T cells was measured using CellEventTM Caspase 3/7 Green Flow Cytometry Assay
Kit (Life Technology), per the manufacturer’s instructions. Brieﬂy, T cells were
stimulated with 5 μg/mL anti-CD3 and 1 μg/mL anti-CD28 antibodies for the given
time points. CellEvent Caspase 3/7 Green Detection Reagent was added to T cell
culture, followed by 30 min incubation at 37 °C, 5% CO2. Samples were immedi-
ately run on LSR II cytometer (BD Biosciences) and data analyzed using FlowJo
Software (Treestar).
Western blotting analysis. To prepare samples for western blot, single cell sus-
pension of splenocytes was prepared from mice of indicated genotypes to detect the
presence or absence of RIPK1, RIPK3, and TRADD. T cells were enriched from the
spleen and lymph nodes of mice of indicated genotypes by negative selection using
MojoSort Mouse CD3 T cell Isolation kit (Biolegend, #480031) and stimulated with
5 μg/mL anti-CD3 and 1 μg/mL anti-CD28 antibodies in cRPMI for 16 h or with 1x
eBioscience Cell Stimulation Cocktail of PMA/Ionomycin (Invitrogen) for 5 min.
Fibroblasts were stimulated with 10 ng/mL TNFα or 1 μg/mL LPS for indicated
time points. Cell lysates were prepared in cold RIPA lysis buffer (50 mM Tris pH
8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 1 mM phe-
nylmethyl sulphonyl ﬂuoride (PMSF), and 1X Halt protease inhibitor cocktail
(Thermo Scientiﬁc). Additional inhibitors were added when probing for phospho-
speciﬁc proteins (50 mM β-glycerophosphate, 1 mM sodium vanadate, 10 mM
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sodium ﬂuoride). Proteins (40 μg) were separated on a 10% SDS-PAGE gel and
transferred to a nitrocellulose membrane. Membranes were blocked with 5% milk
in TBST and blotted with antibodies speciﬁc for RIPK1 (BD Biosciences, #610459),
RIPK3 (ProSci, #2283), TRADD (Santa Cruz, sc7868), cFLIP (Alexis Biochemicals,
ALX-804-127), Bcl-XL (Cell Signaling #2764), total p65 (Cell Signaling #3034), or
β-Actin (Sigma Aldrich, A-5441) in 5% milk in TBST at 4 °C overnight. For
phospho-speciﬁc antibodies, membranes were blocked with 5% BSA in TBST for 1
h at room temperature and blotted overnight with anti-phosphorylated p65 (Cell
Signaling Technology, #3033) in 5% BSA in TBST. Membranes were stained with
HRP-conjugated secondary antibodies at room temperature for 1 h. Membranes
were treated with Western Lightning Plus-ECL (Perkin Elmer, NEL105001EA) and
developed using X-Ray ﬁlm or FluorChem M Western Blot Imaging machine
(ProteinSimple). Quantiﬁcation of signals on X-ray ﬁlms was performed using the
ImageJ software. Uncropped gels are provided in the Source Data ﬁle.
TNFα-induced shock. Ten micrograms of TNFα (Sino Biological) was injected
intravenously into mice. Mice were monitored for survival and core body tem-
perature every 2 h for 10 h and at 24 h. Core body temperature was taken with a
MicroTherma 2T Hand Held thermometer with rectal probe (Braintree Scientiﬁc).
Mice were euthanized if moribund or body temperature dropped below 23.6 °C.
Statistical analysis. Data is represented as mean ± standard error of the mean
(SEM). Student’s t-tests were performed using Prism software (Graphpad Software,
Inc.) to determine p value. A p value < 0.05 was considered signiﬁcant. Logrank
tests were performed to compare survival of various genotypes in Kaplan Meier
plots. Chi square analysis was performed to determine signiﬁcance of genotype
tables.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the ﬁndings of this study are available within the Article and its
Supplementary Information or, on reasonable request, from the corresponding author.
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